{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-078375","form_type":"8-K","ticker":"OKUR","cik":"0001637715","company_name":"OnKure Therapeutics, Inc.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.157583+00:00","generated_at":"2026-05-20T08:11:13.977161+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"OnKure shareholders elect Manke and Saccomano as Class I directors, ratify KPMG as auditor for FY2025","bullets":["Dr. Isaac Manke elected with 4,589,481 for, 882,303 withheld; Dr. Nicholas Saccomano with 5,209,380 for, 262,404 withheld.","KPMG LLP ratified as independent auditor for fiscal year ending December 31, 2025 (6,750,408 for, 111,715 against, 208 abstain).","Both directors will serve until the 2028 annual meeting of stockholders.","Broker non-votes totaled 1,390,547 for each director proposal."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-078375","json":"https://secwatch.observer/filing/0000950170-25-078375.json","markdown":"https://secwatch.observer/filing/0000950170-25-078375.md","text":"https://secwatch.observer/filing/0000950170-25-078375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/0000950170-25-078375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/okur-20250527.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T08:11:13.977161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}